These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33931443)

  • 1. Topography of transcriptionally active chromatin in glioblastoma.
    Xu L; Chen Y; Huang Y; Sandanaraj E; Yu JS; Lin RY; Dakle P; Ke XY; Chong YK; Koh L; Mayakonda A; Nacro K; Hill J; Huang ML; Gery S; Lim SW; Huang Z; Xu Y; Chen J; Bai L; Wang S; Wakimoto H; Yeo TT; Ang BT; Müschen M; Tang C; Tan TZ; Koeffler HP
    Sci Adv; 2021 Apr; 7(18):. PubMed ID: 33931443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Insights into Mesenchymal Signatures in Glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Date I
    Acta Med Okayama; 2022 Oct; 76(5):489-502. PubMed ID: 36352795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalent Chromatin Domains in Glioblastoma Reveal a Subtype-Specific Signature of Glioma Stem Cells.
    Hall AW; Battenhouse AM; Shivram H; Morris AR; Cowperthwaite MC; Shpak M; Iyer VR
    Cancer Res; 2018 May; 78(10):2463-2474. PubMed ID: 29549165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome analyses reveal molecular mechanisms underlying phenotypic differences among transcriptional subtypes of glioblastoma.
    Pan YB; Wang S; Yang B; Jiang Z; Lenahan C; Wang J; Zhang J; Shao A
    J Cell Mol Med; 2020 Apr; 24(7):3901-3916. PubMed ID: 32091665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin run-on and sequencing maps the transcriptional regulatory landscape of glioblastoma multiforme.
    Chu T; Rice EJ; Booth GT; Salamanca HH; Wang Z; Core LJ; Longo SL; Corona RJ; Chin LS; Lis JT; Kwak H; Danko CG
    Nat Genet; 2018 Nov; 50(11):1553-1564. PubMed ID: 30349114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma.
    Mack SC; Singh I; Wang X; Hirsch R; Wu Q; Villagomez R; Bernatchez JA; Zhu Z; Gimple RC; Kim LJY; Morton A; Lai S; Qiu Z; Prager BC; Bertrand KC; Mah C; Zhou W; Lee C; Barnett GH; Vogelbaum MA; Sloan AE; Chavez L; Bao S; Scacheri PC; Siqueira-Neto JL; Lin CY; Rich JN
    J Exp Med; 2019 May; 216(5):1071-1090. PubMed ID: 30948495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.
    Zhang JX; Zhang J; Yan W; Wang YY; Han L; Yue X; Liu N; You YP; Jiang T; Pu PY; Kang CS
    Neuro Oncol; 2013 Mar; 15(3):279-89. PubMed ID: 23295773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal and Proneural Subtypes of Glioblastoma Disclose Branching Based on GSC Associated Signature.
    Steponaitis G; Tamasauskas A
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma.
    Gill BJ; Pisapia DJ; Malone HR; Goldstein H; Lei L; Sonabend A; Yun J; Samanamud J; Sims JS; Banu M; Dovas A; Teich AF; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Sims PA; Canoll P
    Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12550-5. PubMed ID: 25114226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspective of mesenchymal transformation in glioblastoma.
    Kim Y; Varn FS; Park SH; Yoon BW; Park HR; Lee C; Verhaak RGW; Paek SH
    Acta Neuropathol Commun; 2021 Mar; 9(1):50. PubMed ID: 33762019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
    Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma.
    He X; Zhang S; Chen J; Li D
    Cancer Med; 2019 May; 8(5):2031-2040. PubMed ID: 30848102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression.
    Murata H; Yoshimoto K; Hatae R; Akagi Y; Mizoguchi M; Hata N; Kuga D; Nakamizo A; Amano T; Sayama T; Iihara K
    J Neurooncol; 2015 Oct; 125(1):33-41. PubMed ID: 26272600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma.
    Johnston MJ; Nikolic A; Ninkovic N; Guilhamon P; Cavalli FMG; Seaman S; Zemp FJ; Lee J; Abdelkareem A; Ellestad K; Murison A; Kushida MM; Coutinho FJ; Ma Y; Mungall AJ; Moore R; Marra MA; Taylor MD; Dirks PB; Pugh TJ; Morrissy S; St Croix B; Mahoney DJ; Lupien M; Gallo M
    Genome Res; 2019 Aug; 29(8):1211-1222. PubMed ID: 31249064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
    Patil V; Mahalingam K
    Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
    Verhaak RG; Hoadley KA; Purdom E; Wang V; Qi Y; Wilkerson MD; Miller CR; Ding L; Golub T; Mesirov JP; Alexe G; Lawrence M; O'Kelly M; Tamayo P; Weir BA; Gabriel S; Winckler W; Gupta S; Jakkula L; Feiler HS; Hodgson JG; James CD; Sarkaria JN; Brennan C; Kahn A; Spellman PT; Wilson RK; Speed TP; Gray JW; Meyerson M; Getz G; Perou CM; Hayes DN;
    Cancer Cell; 2010 Jan; 17(1):98-110. PubMed ID: 20129251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
    Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
    Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.